首页> 外文期刊>Disease markers >Immunosenescent CD57+CD4+T-cells Accumulate and Contribute to Interferon-γResponses in HIV Patients Responding Stably to ART
【24h】

Immunosenescent CD57+CD4+T-cells Accumulate and Contribute to Interferon-γResponses in HIV Patients Responding Stably to ART

机译:免疫衰老的CD57 + CD4 + T细胞积累并有助于稳定治疗ART的HIV患者的干扰素-γ反应

获取原文
           

摘要

HIV-infected individuals responding to antiretroviral therapy (ART) after severe CD4+T-cell depletion may retain low responses to recall antigens [eg: cytomegalovirus (CMV)] and altered expression of T-cell co-stimulatory molecules consistent with immunosenescence. We investigated the capacity of phenotypically senescent cells to generate cytokines in HIV patients receiving long-term ART (n= 18) and in healthy controls (n= 10). Memory T-cells were assessed by interferon (IFN)-γELISpot assay and flow cytometrically via IFN-γor IL-2. Proportions of CD57brightCD28nullCD4+T-cells correlated with IFN-γresponses to CMV (p= 0.009) and anti-CD3 (p= 0.002) in HIV patients only. Proportions of CD57brightCD28nullCD8+T-cells and CD8+T-cell IFN-γresponses to CMV peptides correlated in controls but not HIV patients. IL-2 was predominantly produced by CD28+T-cells from all donors, whereas IFN-γwas mostly produced by CD57+T-cells. The findings provide evidence of an accumulation of immunosenescent T-cells able to make IFN-γ. This may influence the pathogenesis of secondary viral infections in HIV patients receiving ART.
机译:严重CD4 + T细胞耗竭后对抗逆转录病毒疗法(ART)作出反应的HIV感染个体可能对召回抗原(例如巨细胞病毒(CMV))保持较低的反应,并改变了与免疫衰老一致的T细胞共刺激分子的表达。我们调查了接受长期抗病毒治疗的HIV患者(n = 18)和健康对照组(n = 10)中表型衰老细胞产生细胞因子的能力。通过干扰素(IFN)-γELISpot分析评估记忆T细胞,并通过IFN-γ或IL-2进行流式细胞术。仅在HIV患者中,CD57brightCD28nullCD4 + T细胞与IFN-γ对CMV(p = 0.009)和抗CD3(p = 0.002)反应相关。 CD57brightCD28nullCD8 + T细胞和CD8 + T细胞IFN-γ对CMV肽的反应比例与对照组相关,但与HIV患者无关。 IL-2主要由所有供体的CD28 + T细胞产生,而IFN-γ主要由CD57 + T细胞产生。这些发现提供了能够制造IFN-γ的免疫衰老T细胞积累的证据。这可能会影响接受ART的HIV患者继发性病毒感染的发病机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号